Atlas Trials

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

Clinical trial NCT04825288 · COMPLETED

Trial details

NCT number
NCT04825288
Sponsor
XBiotech, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2021-05-27
Primary completion
2023-10-26
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.